115 related articles for article (PubMed ID: 25329195)
1. Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.
Anand U; Parikh A; Ugwu MC; Agu RU
Future Med Chem; 2014; 6(12):1381-97. PubMed ID: 25329195
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
3. Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues.
Chemuturi NV; Donovan MD
Mol Pharm; 2007; 4(6):936-42. PubMed ID: 17892261
[TBL] [Abstract][Full Text] [Related]
4. Nasal drug administration: potential for targeted central nervous system delivery.
Graff CL; Pollack GM
J Pharm Sci; 2005 Jun; 94(6):1187-95. PubMed ID: 15858850
[TBL] [Abstract][Full Text] [Related]
5. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro.
Shao D; Massoud E; Clarke D; Cowley E; Renton K; Agu RU
Int J Pharm; 2013 Jan; 441(1-2):334-42. PubMed ID: 23178597
[TBL] [Abstract][Full Text] [Related]
6. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
Oliveira P; Fortuna A; Alves G; Falcao A
Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
[TBL] [Abstract][Full Text] [Related]
7. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
Zhou J; Xu J; Huang Z; Wang M
Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
[TBL] [Abstract][Full Text] [Related]
8. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug delivery studies.
Agu R; MacDonald C; Cowley E; Shao D; Renton K; Clarke DB; Massoud E
Int J Pharm; 2011 Mar; 406(1-2):49-54. PubMed ID: 21220000
[TBL] [Abstract][Full Text] [Related]
10. Nasal route: an alternative approach for antiemetic drug delivery.
Ozsoy Y; Güngör S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
[TBL] [Abstract][Full Text] [Related]
11. Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential.
Agu R; Cowley E; Shao D; Macdonald C; Kirkpatrick D; Renton K; Massoud E
Mol Pharm; 2011 Jun; 8(3):664-72. PubMed ID: 21366347
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.
Ashraf T; Kao A; Bendayan R
Adv Pharmacol; 2014; 71():45-111. PubMed ID: 25307214
[TBL] [Abstract][Full Text] [Related]
13. Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.
Al-Ghabeish M; Scheetz T; Assem M; Donovan MD
Mol Pharm; 2015 Aug; 12(8):2742-54. PubMed ID: 26106909
[TBL] [Abstract][Full Text] [Related]
14. The biological and clinical role of drug transporters at the intestinal barrier.
Oostendorp RL; Beijnen JH; Schellens JH
Cancer Treat Rev; 2009 Apr; 35(2):137-47. PubMed ID: 18986769
[TBL] [Abstract][Full Text] [Related]
15. Prodrug based optimal drug delivery via membrane transporter/receptor.
Yang C; Tirucherai GS; Mitra AK
Expert Opin Biol Ther; 2001 Mar; 1(2):159-75. PubMed ID: 11727527
[TBL] [Abstract][Full Text] [Related]
16. Different Culture Conditions Affect Drug Transporter Gene Expression, Ultrastructure, and Permeability of Primary Human Nasal Epithelial Cells.
Kreft ME; Tratnjek L; Lasič E; Hevir N; Rižner TL; Kristan K
Pharm Res; 2020 Aug; 37(9):170. PubMed ID: 32820417
[TBL] [Abstract][Full Text] [Related]
17. Solute carriers as drug targets: current use, clinical trials and prospective.
Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB
Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903
[TBL] [Abstract][Full Text] [Related]
18. Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa.
Chemuturi NV; Haraldsson JE; Prisinzano T; Donovan M
Life Sci; 2006 Aug; 79(14):1391-8. PubMed ID: 16733058
[TBL] [Abstract][Full Text] [Related]
19. SLC transporters as therapeutic targets: emerging opportunities.
Lin L; Yee SW; Kim RB; Giacomini KM
Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
[TBL] [Abstract][Full Text] [Related]
20. Organic cation transporters in human nasal primary culture: expression and functional activity.
Shao D; Massoud E; Anand U; Parikh A; Cowley E; Clarke D; Agu RU
Ther Deliv; 2013 Apr; 4(4):439-51. PubMed ID: 23557285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
